SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-032034
Filing Date
2012-05-02
Accepted
2012-05-02 16:18:40
Documents
13
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12-6748_110q.htm 10-Q 911943
2 EX-10.9 a12-6748_1ex10d9.htm EX-10.9 102031
3 EX-10.36 a12-6748_1ex10d36.htm EX-10.36 51833
4 EX-10.37 a12-6748_1ex10d37.htm EX-10.37 57967
5 EX-31.1 a12-6748_1ex31d1.htm EX-31.1 12918
6 EX-31.2 a12-6748_1ex31d2.htm EX-31.2 13713
7 EX-32 a12-6748_1ex32.htm EX-32 11464
  Complete submission text file 0001104659-12-032034.txt   7597062

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT thrx-20120331.xml EX-101.INS 958775
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT thrx-20120331.xsd EX-101.SCH 69708
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT thrx-20120331_cal.xml EX-101.CAL 50398
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT thrx-20120331_lab.xml EX-101.LAB 1209992
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT thrx-20120331_pre.xml EX-101.PRE 543610
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT thrx-20120331_def.xml EX-101.DEF 395691
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 12805522
SIC: 2834 Pharmaceutical Preparations